The Idiopathic Intracranial Hypertension Treatment Trial: A Long-Time Coming but Worth the Wait

J Neuroophthalmol. 2016 Mar;36(1):1-3. doi: 10.1097/WNO.0000000000000347.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Acetazolamide / adverse effects
  • Acetazolamide / therapeutic use*
  • Carbonic Anhydrase Inhibitors / adverse effects
  • Carbonic Anhydrase Inhibitors / therapeutic use*
  • Clinical Trials as Topic*
  • Humans
  • Pseudotumor Cerebri / diagnosis
  • Pseudotumor Cerebri / drug therapy*
  • Vision Disorders / drug therapy
  • Visual Fields / drug effects

Substances

  • Carbonic Anhydrase Inhibitors
  • Acetazolamide